Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - Other
Status
Ongoing, recruiting
Participants planned
12
Countries
1
Sites
1
For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries
Key facts
- Sponsor
- Haleon CH SARL
- Participant type
- Healthy volunteers
- Age range
- 18-64 years, 65+ years
- Gender
- Male and Female
- Therapeutic area
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02]
- Trial duration
- 26 May 2026 → ongoing
- Decision date (initial)
- 2026-04-09
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- No
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Haleon CH SARL
- Sponsor organisation
- Haleon CH SARL
- Address
- Case Postale 1279
- City
- Nyon 1
- Postcode
- 1260
- Country
- Switzerland
Scientific contact point
- Organisation
- Haleon CH SARL
- Contact name
- Nora Schneider
Public contact point
- Organisation
- Haleon CH SARL
- Contact name
- Nora Schneider
Locations
1 EU/EEA country · 1 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Germany | Ongoing, recruiting | 12 | 1 |
| Rest of world | — | 0 | — |
Investigational sites
SGS proderm GmbH
SGS proderm Site, Kiebitzweg 2, 22869, Schenefeld
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Germany | 2026-05-26 | 2026-05-26 |
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2026-03-04 | Germany | Acceptable 2026-04-01
|
2026-04-09 |